ZonMw funds research into the quality of health care in the Netherlands
For instance by supporting nurses and care staff and by strengthening health care infrastructure. In doing so, we look at the different elements involved in health care, including the patient perspective, the various organisations involved, the care professional, and the social impact.
The Netherlands Organisation for Health Research and Development (ZonMw) is co-host of the 18th International Conference on Integrated Care (ICIC) in Utrecht, 23-25th May 2018. Our aim is to promote quality and innovation of health research in order to make health care better and to keep it affordable. Therefor we invest in integrated care.
Nurses and caregivers together form the largest group of healthcare professionals in the Netherlands. They work in all sectors of healthcare and form an essential link to quality prevention, care and support for citizens, patients and healthcare professionals. ZonMw supports nurses and caregivers by providing the knowledge needed to be able to carry out this pivotal role effectively.
The goal of the programme “From Knowledge to Action II” is promoting the quality of nursing and care by carrying out research, developing and testing innovations, and implementation and guaranteeing of improvements and innovations in daily practice. In order to strengthen the research infrastructure for scientific research into nursing and care, no separate research projects will be renumerated in this programme, only lines of research. A line of research consists of a number of related projects.
GloPID-R is pleased to welcome the Netherlands Organisation for Health Research and Development (ZonMw), represented by Suzanne Verver, into the network. GloPID-R is a unique international network of major research funding organizations. The network of 27 countries facilitates a rapid and effective research response to infectious disease outbreaks.
KNAW (Royal Netherlands Academy of Arts and Sciences), NWO (Netherlands Organisation for Scientific Research) and ZonMw (Netherlands Organisation for Health Research and Development) will sign the San Francisco Declaration on Research Assessment (DORA) on 18 April.
On April 1st 2019 the kick-off meeting of the European public-private partnership VALUE-Dx took place. This European-wide approach aims to generate evidence on the medical, economic, and public health value of diagnostics in tackling antimicrobial resistance (AMR). As a member of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), ZonMw participates in this consortium.
17 researchers who have recently received their PhDs can do their research at foreign research institutes thanks to a Rubicon grant from NWO. They will investigate, amongst other things, artificial intelligence for improved ultrasonography, Imaging muscle function in ALS patients, Printing living tissue through protective cell coating and new blood vessel formation.
While the pharmaceutical, medical technologies, chemical, cosmetics and food industries are increasingly seeking solutions to improve for example their prediction of clinical efficacy and/or risk and safety assessments without the use of animals, the solutions are still insufficient;
Societal demand for animal-free testing is increasing and there is a need for new innovations to improve human health, a stimulation of this research field is therefore needed;